Physician profile
Todd Koch
NPI 1881169241
$930.90
in general payments reported to CMS, 2019-2025
14 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $77.21 · 2024: $282 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.62 | 2023-2025 | |
| Shield Therapeutics INC | $174.84 | 2025 | |
| Lilly USA, LLC | $82.31 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $79.68 | 2023-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $68.62 | 2024-2025 | |
| Esperion Therapeutics, INC. | $34.24 | 2024-2025 | Nexletol |
| Exact Sciences Corporation | $30.55 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $29.27 | 2025 | Airsupra |
| Teva Pharmaceuticals USA, INC. | $20.60 | 2025 | Austedo Xr |
| Astellas Pharma US INC | $17.89 | 2024 | Veozah |
| Inspire Medical Systems, INC. | $16.16 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $15.84 | 2024 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $15.23 | 2024 | Evenity, Prolia |
| Abiomed | $15.05 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.